Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Pharma Mar Free Cash Flow : 62.89M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 62.89M |
| March 31, 2026 | 69.93M |
| December 31, 2025 | 54.32M |
| September 30, 2025 | 19.81M |
| June 30, 2025 | 2.270M |
| March 31, 2025 | -18.69M |
| December 31, 2024 | -9.354M |
| September 30, 2024 | -18.98M |
| June 30, 2024 | -32.10M |
| March 31, 2024 | -37.74M |
| December 31, 2023 | -32.00M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| June 30, 2022 | 46.18M |
| March 31, 2022 | 44.93M |
| December 31, 2021 | 20.70M |
| September 30, 2021 | 34.01M |
| June 30, 2021 | 22.93M |
| March 31, 2021 | 126.22M |
| December 31, 2020 | 304.76M |
| September 30, 2020 | 290.27M |
| June 30, 2020 | 278.47M |
| March 31, 2020 | 176.94M |
| Date | Value |
|---|---|
| December 31, 2019 | -33.76M |
| September 30, 2019 | -26.76M |
| June 30, 2019 | -11.98M |
| March 31, 2019 | -26.43M |
| December 31, 2018 | -21.35M |
| September 30, 2018 | -26.32M |
| June 30, 2018 | -32.27M |
| March 31, 2018 | -28.06M |
| December 31, 2017 | -7.390M |
| September 30, 2017 | -1.535M |
| June 30, 2017 | 2.656M |
| March 31, 2017 | 7.237M |
| December 31, 2016 | -16.27M |
| September 30, 2016 | -4.222M |
| June 30, 2016 | -1.305M |
| March 31, 2016 | -10.19M |
| December 31, 2015 | 1.870M |
| September 30, 2015 | -9.187M |
| June 30, 2015 | -5.868M |
| March 31, 2015 | 2.697M |
| December 31, 2014 | 15.55M |
| September 30, 2014 | 28.66M |
| June 30, 2014 | 28.18M |
| March 31, 2014 | 21.47M |
| December 31, 2013 | 19.56M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oryzon Genomics SA | -- |
| Grifols SA | 738.77M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alkermes Plc | 221.65M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.848M |
| Cash from Investing (Quarterly) | -37.88M |
| Cash from Financing (Quarterly) | -0.0493M |
| Free Cash Flow Per Share (Quarterly) | 0.0679 |
| Free Cash Flow to Equity (Quarterly) | 3.541M |
| Free Cash Flow to Firm (Quarterly) | 1.177M |
| Free Cash Flow Yield | 3.82% |